Günter Wolf

5.4k total citations · 1 hit paper
70 papers, 4.5k citations indexed

About

Günter Wolf is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Günter Wolf has authored 70 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Cardiology and Cardiovascular Medicine and 19 papers in Oncology. Recurrent topics in Günter Wolf's work include Renin-Angiotensin System Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Chronic Kidney Disease and Diabetes (9 papers). Günter Wolf is often cited by papers focused on Renin-Angiotensin System Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Chronic Kidney Disease and Diabetes (9 papers). Günter Wolf collaborates with scholars based in Germany, United States and France. Günter Wolf's co-authors include Rolf A.K. Stahl, Fuad N. Ziyadeh, Sheldon Chen, Dong Cheol Han, Gunther Zahner, Friedrich Thaiss, Stuart J. Shankland, Ulrich Wenzel, Regine Schroeder and Udo Helmchen and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Günter Wolf

69 papers receiving 4.4k citations

Hit Papers

Leptin and renal disease 2002 2026 2010 2018 2002 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Günter Wolf 1.6k 1.5k 1.1k 722 448 70 4.5k
Sergio Mezzano 2.2k 1.4× 2.0k 1.3× 1.3k 1.1× 881 1.2× 655 1.5× 131 6.2k
Mónica Rupérez 1.4k 0.9× 581 0.4× 1.7k 1.5× 821 1.1× 408 0.9× 29 4.0k
Christos Chatziantoniou 1.4k 0.9× 940 0.6× 1.3k 1.1× 588 0.8× 510 1.1× 133 4.2k
Friedrich Thaiss 1.2k 0.8× 1.3k 0.8× 813 0.7× 554 0.8× 577 1.3× 116 4.9k
Hirotoshi Morii 1.3k 0.8× 2.2k 1.5× 856 0.8× 919 1.3× 847 1.9× 169 5.8k
José Manuel Valdivielso 1.2k 0.8× 1.8k 1.2× 856 0.8× 793 1.1× 832 1.9× 181 6.0k
Andrew Advani 1.6k 1.1× 798 0.5× 781 0.7× 960 1.3× 677 1.5× 104 3.9k
Jean–Daniel Sraer 1.6k 1.0× 948 0.6× 2.0k 1.8× 1.5k 2.1× 786 1.8× 105 5.1k
Sheldon Chen 2.5k 1.6× 3.1k 2.1× 895 0.8× 1.1k 1.5× 787 1.8× 63 7.0k
Wendy C. Burns 1.3k 0.9× 931 0.6× 1.1k 1.0× 1.1k 1.5× 365 0.8× 32 3.9k

Countries citing papers authored by Günter Wolf

Since Specialization
Citations

This map shows the geographic impact of Günter Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günter Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günter Wolf more than expected).

Fields of papers citing papers by Günter Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günter Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günter Wolf. The network helps show where Günter Wolf may publish in the future.

Co-authorship network of co-authors of Günter Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Günter Wolf. A scholar is included among the top collaborators of Günter Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günter Wolf. Günter Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaemmerer, Daniel, Gabriele Lehmann, Günter Wolf, Utz Settmacher, & Merten Hommann. (2010). Treatment of osteoporosis after liver transplantation with ibandronate. Transplant International. 23(7). 753–759. 18 indexed citations
2.
Gerth, Jens, Martin Busch, Florian Oyen, et al.. (2007). Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both?. Clinical Nephrology. 68(12). 405–411. 2 indexed citations
3.
Panzer, Ulf, Oliver M. Steinmetz, Tobias Meyer, et al.. (2005). Compartment-Specific Expression and Function of the Chemokine IP-10/CXCL10 in a Model of Renal Endothelial Microvascular Injury. Journal of the American Society of Nephrology. 17(2). 454–464. 78 indexed citations
4.
Wolf, Günter. (2004). An expensive multifactorial renal failure. Nephrology Dialysis Transplantation. 19(11). 2921–2922. 1 indexed citations
5.
Wolf, Günter, et al.. (2003). Angiotensin II–induced hypertrophy of proximal tubular cells requires p27Kip1. Kidney International. 64(1). 71–81. 27 indexed citations
6.
Gerth, Jens, Jörg Kriegsmann, Rolf A.K. Stahl, et al.. (2002). Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney International. 61(1). 68–79. 20 indexed citations
7.
Wenzel, Ulrich, Friedrich Thaiss, U. Helmchen, Rolf A.K. Stahl, & Günter Wolf. (2002). Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis11See Editorial by de Zeeuw, p. 1176.. Kidney International. 61(3). 1020–1029. 18 indexed citations
8.
Wolf, Günter & Rolf A.K. Stahl. (2002). Remembrance of things past: tumoural calcifications in a haemodialysis patient. Nephrology Dialysis Transplantation. 17(2). 304–307. 1 indexed citations
9.
Wolf, Günter, Ulrich Wenzel, Kevin D. Burns, et al.. (2002). Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors11See Editorial by Luft, p. 2272.. Kidney International. 61(6). 1986–1995. 185 indexed citations
10.
Panzer, Ulf, Friedrich Thaiss, Gunther Zahner, et al.. (2001). Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney International. 59(5). 1762–1769. 91 indexed citations
11.
Wolf, Günter, et al.. (2001). Thrombosis associated with cytomegalovirus infection in patients with ANCA-positive vasculitis. American Journal of Kidney Diseases. 38(5). E27–E27. 25 indexed citations
12.
Chen, Sheldon, Günter Wolf, & Fuad N. Ziyadeh. (2001). The Renin-Angiotensin System in Diabetic Nephropathy. Contributions to nephrology. 212–221. 10 indexed citations
13.
Wolf, Günter, Ulf Panzer, & Rolf A.K. Stahl. (2000). Regulatory peptides and their antagonists in nephropathies. Current Opinion in Nephrology & Hypertension. 9(3). 233–239. 5 indexed citations
14.
Wolf, Günter. (2000). Cell cycle regulation in diabetic nephropathy. Kidney International. 58. S59–S66. 133 indexed citations
15.
Schroeder, Regine, et al.. (2000). Reactive Oxygen Species Stimulate p44/42 Mitogen-Activated Protein Kinase and Induce p27Kip1. Journal of the American Society of Nephrology. 11(8). 1387–1397. 90 indexed citations
16.
Schneider, André, Ulf Panzer, Gunther Zahner, et al.. (1999). Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β. Kidney International. 56(1). 135–144. 90 indexed citations
17.
Wolf, Günter. (1999). Molecular mechanisms of renal hypertrophy: Role of p27Kip1. Kidney International. 56(4). 1262–1265. 34 indexed citations
18.
Wolf, Günter, Friedrich Thaiss, & Rolf A.K. Stahl. (1995). CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTS. Transplantation. 60(3). 237–241. 121 indexed citations
19.
Wolf, Günter. (1992). Changing Concepts of Compensatory Renal Growth: From Humoral Pathology to Molecular Biology. American Journal of Nephrology. 12(5). 369–373. 6 indexed citations
20.
Wolf, Günter, Friedrich Thaiss, Jürgen E. Scherberich, W. Schoeppe, & Rolf A.K. Stahl. (1990). Glomerular angiotensinase A in the rat: Increase of enzyme activity following renal ablation. Kidney International. 38(5). 862–868. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026